Rahmouni K
Hypertension. 2024; 81(6):1233-1243.
PMID: 38533662
PMC: 11096079.
DOI: 10.1161/HYPERTENSIONAHA.124.22066.
Nyarko O, Sucharov C
J Cardiovasc Aging. 2023; 3(3).
PMID: 37484982
PMC: 10361342.
DOI: 10.20517/jca.2023.15.
Perrone M, Aimo A, Bernardini S, Clerico A
Int J Mol Sci. 2023; 24(1).
PMID: 36614282
PMC: 9820990.
DOI: 10.3390/ijms24010844.
Manaserh I, Bledzka K, Junker A, Grondolsky J, Schumacher S
JACC Basic Transl Sci. 2022; 7(6):563-579.
PMID: 35818501
PMC: 9270572.
DOI: 10.1016/j.jacbts.2022.01.010.
Cai H, Men H, Cao P, Zheng Y
Exp Ther Med. 2021; 22(6):1463.
PMID: 34737803
PMC: 8561773.
DOI: 10.3892/etm.2021.10898.
The Sick Adipose Tissue: New Insights Into Defective Signaling and Crosstalk With the Myocardium.
Bermudez V, Duran P, Rojas E, Diaz M, Rivas J, Nava M
Front Endocrinol (Lausanne). 2021; 12:735070.
PMID: 34603210
PMC: 8479191.
DOI: 10.3389/fendo.2021.735070.
RAAS: A Convergent Player in Ischemic Heart Failure and Cancer.
Garcia-Garduno T, Padilla-Gutierrez J, Cambron-Mora D, Valle Y
Int J Mol Sci. 2021; 22(13).
PMID: 34281199
PMC: 8268500.
DOI: 10.3390/ijms22137106.
Mining Metabolomics in Mitral Valve Disease.
Scheibe E, Grueter C
J Am Heart Assoc. 2021; 10(9):e020726.
PMID: 33890481
PMC: 8200764.
DOI: 10.1161/JAHA.121.020726.
Metabolic Crosstalk between the Heart and Fat.
Ferrero K, Koch W
Korean Circ J. 2020; 50(5):379-394.
PMID: 32096362
PMC: 7098822.
DOI: 10.4070/kcj.2019.0400.
Reverse Cardio-Oncology: Cancer Development in Patients With Cardiovascular Disease.
Aboumsallem J, Moslehi J, de Boer R
J Am Heart Assoc. 2020; 9(2):e013754.
PMID: 31960736
PMC: 7033852.
DOI: 10.1161/JAHA.119.013754.
Cancer and heart disease: associations and relations.
de Boer R, Meijers W, van der Meer P, Van Veldhuisen D
Eur J Heart Fail. 2019; 21(12):1515-1525.
PMID: 31321851
PMC: 6988442.
DOI: 10.1002/ejhf.1539.
Metabolic modulation predicts heart failure tests performance.
Contaifer Jr D, Buckley L, Wohlford G, Kumar N, Morriss J, Ranasinghe A
PLoS One. 2019; 14(6):e0218153.
PMID: 31220103
PMC: 6586291.
DOI: 10.1371/journal.pone.0218153.
Regulation of cardiac transcription by thyroid hormone and Med13.
Minerath R, Dewey C, Hall D, Grueter C
J Mol Cell Cardiol. 2019; 129:27-38.
PMID: 30769017
PMC: 6510257.
DOI: 10.1016/j.yjmcc.2019.01.007.
Modeling Human Cardiac Hypertrophy in Stem Cell-Derived Cardiomyocytes.
Ovchinnikova E, Hoes M, Ustyantsev K, Bomer N, de Jong T, van der Mei H
Stem Cell Reports. 2018; 10(3):794-807.
PMID: 29456183
PMC: 5918264.
DOI: 10.1016/j.stemcr.2018.01.016.
CVD and Oxidative Stress.
Cervantes Gracia K, Llanas-Cornejo D, Husi H
J Clin Med. 2017; 6(2).
PMID: 28230726
PMC: 5332926.
DOI: 10.3390/jcm6020022.
Cardiac Med1 deletion promotes early lethality, cardiac remodeling, and transcriptional reprogramming.
Spitler K, Ponce J, Oudit G, Hall D, Grueter C
Am J Physiol Heart Circ Physiol. 2017; 312(4):H768-H780.
PMID: 28159809
PMC: 5407164.
DOI: 10.1152/ajpheart.00728.2016.